Original Article
Percutaneous Balloon Valvuloplasty Compared with Open Surgical Commissurotomy for Mitral Stenosis
N Engl J Med 1994; 331:961-967October 13, 1994
- Abstract
Background
Percutaneous balloon mitral valvuloplasty has been proposed as an alternative to open surgical commissurotomy for the treatment of rheumatic mitral-valve stenosis.
Methods
We enrolled 60 patients with severe mitral stenosis and favorable valvular anatomy in a prospective, randomized trial comparing the two procedures. All patients underwent cardiac catheterization before the procedure and one week, six months, and three years thereafter. Hemodynamic data were analyzed by investigators who were blinded to the patients' treatment assignments.
Results
Mitral-valve areas improved initially in both groups, from a mean (±SD) of 0.9 ±0.3 cm2 to 2.1 ±0.6 cm2 in the balloon-valvuloplasty group (30 patients; P<0.01) and from 0.9 ±0.3 cm2 to 2.0 ±0.6 cm2 in the surgical group (30 patients; P<0.001). Although improvement was maintained in both groups, mitral-valve areas were greater in the patients in the balloon-valvuloplasty group at three years (2.4 ±0.6 cm2, vs. 1.8 ±0.4 cm2 in the surgery group; P<0.001). Restenosis occurred in three patients in the balloon-valvuloplasty group and four in the surgery group. One patient in the balloon-valvuloplasty group died of an apparent stroke after 2.5 years; four patients in the balloon-valvuloplasty group had residual atrial septal defects, and three patients (two in the balloon-valvuloplasty group and one in the surgery group) were judged to have severe mitral regurgitation. Seventy-two percent of the patients who underwent balloon valvuloplasty and 57 percent of the surgically treated patients were in New York Heart Association functional class I (i.e., they had no cardiovascular symptoms) at three years. No patient was lost to follow-up.
Conclusions
In the treatment of mitral stenosis, balloon valvuloplasty and open surgical commissurotomy have comparable initial results and low rates of restenosis, and both produce good functional capacity for at least three years. The potential complications associated with balloon valvuloplasty should be noted. The better hemodynamic results at three years, lower cost, and elimination of the need for thoracotomy suggest that balloon valvuloplasty should be considered for all patients with favorable mitral-valve anatomy.
Media in This Article
Figure 2
Cumulative Frequency Distribution of Mitral-Valve Areas in Patients Who Underwent Balloon Valvuloplasty (Open Symbols) or Open Surgical Commissurotomy (Solid Symbols).Figure 1
Hemodynamic Variables at Base Line and One Week, Six Months, and Three Years after Balloon Mitral Valvuloplasty or Open Surgical Commissurotomy.Article Activity
- Article
Percutaneous balloon mitral commissurotomy (valvuloplasty), first described in 1984,1 has had good short- and intermediate-term results2-6. In a randomized trial in patients with favorable anatomical features,7 we reported that the outcome of balloon valvuloplasty was similar to that of closed surgical commissurotomy. Although the superiority of open over closed commissurotomy in patients with ideal valvular anatomy remains controversial,8 open commissurotomy (which allows the inspection of the valve and the separation of fused chordae under direct vision) is the preferred treatment for severe mitral stenosis in most industrialized nations9. We therefore compared the results of percutaneous balloon mitral valvuloplasty with those of open mitral commissurotomy in a randomized, prospective trial, with serial invasive and noninvasive testing of all patients through three years of follow-up.
Methods
Study Design
All the patients were enrolled during a three-week period in August and September 1989. Patients with severe rheumatic mitral-valve stenosis were screened in the clinics of the Nizam's Institute of Medical Sciences, Hyderabad, India, and referred for enrollment if they were 15 through 75 years of age and had no history of other cardiac disease or stroke, were in sinus rhythm, and had no severe subvalvular disease, calcification, or more than mild mitral regurgitation. A history was obtained from all patients, who also underwent physical examination, two-dimensional echocardiography and color Doppler study, exercise testing, chest radiography, and quality-of-life evaluation. A mitral-valve echocardiographic score was derived according to the criteria of Wilkins and colleagues,10 in which a maximum of 4 points was assigned according to the severity of each of four characteristics: mitral-valve-leaflet calcification, impaired mobility, thickening of the valve, and subvalvular disease (0 indicates normal and 4 the most severe abnormality); the four separate scores were totaled to give the overall echocardiographic score. A committee of cardiologists and a committee of cardiac surgeons screened each patient; both groups had to agree that the patient was a suitable candidate for their procedures. The protocol was approved by the institutional review board of the Wayne State University School of Medicine and the Human Investigation Committee of the Nizam's Institute of Medical Sciences. Informed consent was obtained from all patients, and the study was conducted in accordance with the guidelines of the 1975 Helsinki Declaration on the Rights of Human Subjects Enrolled in Medical Research.
Cardiac catheterization was performed at base line and one week, six months, and three years after the procedure. Cardiac output was determined by the Fick technique; the Flamm correction was applied if the oxygen saturation in the pulmony artery was more than 6 percent higher than that in the superior vena cava11. All cardiac-catheterization data were photocopied, coded with use of random numbers to mask the patient's identity, the group assignment, and the time at which data were obtained and were analyzed by an investigator remote from the study site.
We assessed functional capacity by treadmill exercise testing according to a modified Naughton protocol and by the interview-based Duke Activity Status Index,12 generating a score based on the percentage of activities (related to personal care, ambulation, household tasks, sexual function, and recreation) that individual patients could perform without substantial limitation.
The patients were randomly assigned to treatment groups after all base-line data were obtained. Those assigned to balloon valvuloplasty underwent the procedure after initial catheterization; for this procedure we used a modified version13 of the technique of Al Zaibag and colleagues14. After a single atrial transseptal puncture, an 8-French Mullins sheath (USCI, Billerica, Mass.) was advanced to the left atrium. A balloon flotation catheter was used to cross the mitral valve, after which two 0.035-in. (0.9-mm) Extra Stiff guidewires (Cook, Bloomington, Ind.) were placed in the apex of the left ventricle. An 8-mm septostomy balloon was used to dilate the septum (PE Plus II, USCI), after which two valvuloplasty balloons, 5.5 cm long (Boston Scientific, Watertown, Mass.), were inflated simultaneously across the mitral valve (20 mm and 15 mm in 26 patients; 18 mm and 15 mm in 4 patients). The therapeutic end point was nearly complete elimination of the mitral-valve gradient without a substantial increase in mitral regurgitation.
The patients randomly assigned to open surgical commissurotomy underwent a midline sternotomy, cannulation of the inferior and superior vena cava through the right atrium, and cardiopulmonary bypass (with use of a bubble oxygenator) and moderate systemic hypothermia15. After the aorta was cross-clamped, approximately 1 liter of a cold crystalloid-potassium cardioplegia solution was used to arrest the heart. The mitral valve was approached through a left atriotomy; if fused chordae were noted under the leaflets during commissurotomy, an attempt was made to separate the area of abnormal fusion.
Patients were discharged from the hospital after echocardiography and cardiac catheterization were performed one week after the procedure. The investigators made extensive efforts to maintain communication with patients, whose homes were scattered over a wide geographic area. Patients received laminated identification cards noting their participation in the study and were photographed for identification purposes. Six-month and three-year follow-up examinations were performed during two-week periods in February 1990 and September 1992, with the majority of the investigators present, including cardiologists from both the U.S. and Indian teams and the study statistician.
Statistical Analysis
The prospectively determined primary end point was the mitral-valve area one week, six months, and three years after the procedures. Power calculations were based on data from our previous study7; we estimated that the enrollment of 28 patients in each treatment group would give the study 80 percent power to detect a difference of at least 25 percent in mitral-valve area between the groups. Intraobserver variability was tested and found to be reproducible within a mean (±SD) of 1.2 ±1.8 mm Hg for the pulmonary wedge pressure or the left atrial pressure, 0.02 ±0.03 second for the diastolic filling period, 2.3 ±3.1 beats per minute for the heart rate, and 0.5 ±0.6 mm Hg for the mitral-valve gradient. Because the original formula of Gorlin and Gorlin for calculating the areas of the stenotic mitral valve and other cardiac valves was derived from a group of patients with small valve areas16 and therefore tends to overestimate valve area in high-flow states,17 valve areas greater than 3.0 cm2 were considered to be 3.0 cm2 (all valve areas derived from the formula of Gorlin and Gorlin without truncation are shown in Figure 2Figure 2
Cumulative Frequency Distribution of Mitral-Valve Areas in Patients Who Underwent Balloon Valvuloplasty (Open Symbols) or Open Surgical Commissurotomy (Solid Symbols).). Repeated-measures analysis of variance was performed for continuous variables to assess change over time and the effect of treatment18; between-group and within-group pairwise comparisons were made with the use of the least-squares means. Categorical variables were compared by chi-square analysis. No adjustment was made for multiple comparisons, and all tests of the hypothesis were two-tailed. The results are reported as means ±SD.Results
Study Population
Of the initial 82 patients who underwent cardiac catheterization, 22 were excluded from randomization because of the presence of coexisting myocardial or other valvular disease (7 patients), noncritical mitral stenosis (6), severe pulmonary hypertension (3), low body weight (2), severe subvalvular disease (1), Lutembacher's syndrome (1), the patient's decision not to undergo randomization (1), or left atrial thrombus demonstrated by echocardiography (1). By means of sealed envelopes, the remaining 60 patients were randomly assigned to percutaneous balloon mitral valvuloplasty (n = 30) or open surgical commissurotomy (n = 30) and underwent the assigned procedures within the next several days.
Base-line demographic, hemodynamic, and echocardiographic characteristics and functional-activity ratings are shown in Table 1Table 1
Base-Line Characteristics of Patients Who Underwent Balloon Valvuloplasty or Open Surgical Commissurotomy.. The patients in the two groups were similar in age, New York Heart Association (NYHA) functional class, hemodynamic variables, and echocardiographic scores at study entry. There were more men (P = 0.01) and exercise times were longer (P = 0.03) in the surgery group than in the balloon-valvuloplasty group.Outcome of the Procedures
All 60 patients underwent their assigned procedures. Cardiac catheterization, echocardiography, exercise testing, and quality-of-life evaluation were performed as scheduled for every patient, except for the 3-year study in the patient who died at 2.5 years; no patient was lost to follow-up. Hemodynamic measurements in the two groups are presented in Figure 1Figure 1
Hemodynamic Variables at Base Line and One Week, Six Months, and Three Years after Balloon Mitral Valvuloplasty or Open Surgical Commissurotomy.. The initial improvement in pulmonary-artery wedge pressure, mitral-valve gradient, and mitral-valve area was sustained throughout the three years of follow-up (P<0.001 for the comparison with the base-line values). In both groups, pulmonary-artery wedge pressures were further improved at three years as compared with the values at the one-week or six-month evaluation (P<0.001). Both the mitral-valve gradient and the pulmonary-wedge pressure were lower in the balloon-valvuloplasty group than in the surgery group throughout follow-up, but these differences were not statistically significant. The difference in mitral-valve area between the balloon-valvuloplasty group and the surgery group became significant at three years (P<0.001). The exclusion of patients with evidence of left-to-right shunting on oxymetry or color Doppler echocardiography did not change the above findings. Pulmonary hypertension resolved more slowly in the surgery group; a continuing decrease in pulmonary-artery pressures was noted at six months and at three years.Figure 2 shows the mitral-valve area for each patient plotted against the cumulative percentile distribution of valve areas in each group at base line and at each follow-up evaluation. The balloon-valvuloplasty and surgery groups overlap closely at base line; the curve for the balloon-valvuloplasty group shifts to the right of that for the surgery group at all three follow-ups, demonstrating that the valve areas were consistently larger after balloon valvuloplasty than after surgical commissurotomy.
Functional Capacity
The majority of patients enrolled in this study engaged in at least moderate physical activity despite having severe mitral stenosis at base line. By six months after the procedure, approximately 80 percent were in NYHA functional class I (23 patients in the alloon-valvuloplasty group and 24 in the surgery group), indicating that they had no symptoms; at three years, 21 patients in the balloon-valvuloplasty group and 17 in the surgery group remained in class I. We also compared hemodynamic variables during exercise at three years in the two groups: although the duration of exercise and the exercise gradient were essentially the same, the mean wedge pressure during exercise was significantly greater (P = 0.03) in the patients who underwent surgery (Figure 3Figure 3
Pulmonary-Artery Wedge Pressure and Mitral-Valve Gradient during Exercise and Duration of Exercise at the Three-Year Follow-up Examination.).The scores on the Duke Activity Status Index were similar at base line (Table 1), and improvement persisted through three years (at six months and three years, P<0.001 for the comparison with the base-line values in both groups). The six-month score was higher in the balloon-valvuloplasty group (activities performed easily, 82 percent vs. 72 percent; P = 0.01), but the scores were similar by three years (96 percent vs. 90 percent, P = 0.09).
Complications
No patient had a serious complication during the initial hospitalization. Complications during three years of follow-up are listed in Table 2Table 2
Complications of Percutaneous Balloon Valvuloplasty and Open Mitral Commissurotomy through Three Years of Follow-up.. One patient in the balloon-valvuloplasty group died approximately 2.5 years after valvuloplasty; this patient, a 52-year-old woman, had a valve area of 2.6 cm2 immediately after the procedure; at the 6-month follow-up examination, she had a residual atrial septal defect with a ratio of pulmonary to systemic flow of 2.6. The information provided by her son after her death was consistent with a diagnosis of left hemispheric stroke, dehydration, and subsequent death. One week after the procedure, 13 patients in the balloon-valvuloplasty group and 5 in the surgery group had moderate or severe mitral regurgitation (P = 0.03); mitral insufficiency was classified as severe in 2 who underwent balloon valvuloplasty and none who underwent surgical commissurotomy. At three years, mitral regurgitation was mild or absent in 25 patients in the balloon-valvuloplasty group and 27 in the surgery group; 3 patients had severe mitral regurgitation (2 in the balloon-valvuloplasty group and 1 in the surgery group). No patient had left ventricular dilatation or dysfunction. There were four patients with a pulmonary-to-systemic flow ratio of more than 1.5 at three years, all of whom had undergone atrial septostomy for balloon valvuloplasty. All patients remained in sinus rhythm at the three-year follow-up.By definition, restenosis was indicated by a mitral-valve area of less than 1.5 cm2 and a loss of more than 50 percent of the initial gain after the procedure19,20; three patients in the balloon-valvuloplasty group and four in the surgery group fit these criteria and were scheduled for balloon valvuloplasty.
Cost
We calculated the charges for hospitalization and physicians' fees for the two groups of patients. With accounting for the reuse of disposable balloons in India, the cost of surgery was at least twice that of balloon valvuloplasty; in the United States, on the basis of Medicare reimbursement at Harper Hospital in Detroit, this ratio was nearly three to one.
Discussion
In our patients with severe mitral stenosis, both balloon valvuloplasty and open surgical commissurotomy resulted in sustained improvement through three years of follow-up. Our initial prediction, that the advantages of surgery under direct vision, including controlled separation of fused commissures, would result in a larger mitral-valve area21 and less mitral regurgitation, was not borne out. In addition to the larger mitral-valve areas in the balloon-valvuloplasty group, the preponderance of evidence based on other measurements (mitral-valve gradient, pulmonary-artery wedge pressure, pulmonary-artery pressure, and hemodynamic measurements during exercise) showed trends indicating the superiority of balloon valvuloplasty over surgery.
The occurrence of atrial septal defect in over 10 percent of patients who underwent balloon valvuloplasty is in keeping with published data22 and may reflect two aspects of the technique used in India at that time: the reuse of balloons, a practice that tends to result in a higher profile during withdrawal across the septum, and the use of relatively large, 8-mm septostomy balloons, which were standard at that time. Since the reuse of disposable equipment to limit costs is a standard practice in most parts of the world where mitral stenosis is prevalent, we believe that our results are typical for the double-balloon technique.
Although some increase in mitral regurgitation has been reported to be common during follow-up, severe mitral regurgitation is less common23-25; two patients in the balloon-valvuloplasty group and one in the surgery group were judged to have severe mitral incompetence at three years. Although improvement in the degree of postprocedural mitral regurgitation over time has been reported,26 in our study regurgitation was predominantly mild one week after the procedure. All three patients who had severe mitral regurgitation at three years had at least moderate mitral regurgitation at one week.
It has been postulated that what is labeled restenosis may merely reflect poor initial results. In the seven patients who met the criteria for restenosis, the mean valve area one week after balloon valvuloplasty or surgical commissurotomy was 2.4 ±0.9 cm2, narrowing to 1.4 ±0.1 cm2 at three years, thus representing true restenosis. Although this 12 percent rate of restenosis is in the middle of the 4-to-27-percent range reported in previous studies,20,27-29 earlier reports relied at least in part on clinical criteria, did not include routine follow-up catheterization, and did not approach our 100 percent follow-up. Furthermore, three of our seven patients who had restenosis were in NYHA class I (i.e., they had no cardiac symptoms) despite hemodynamic evidence of severe recurrent mitral stenosis; thus, they would not have been described as having restenosis according to the criteria used by most previous investigators30,31.
In order to minimize the effect of the experience and skills of individual physicians on the results of this study, balloon valvuloplasty was performed by a team of interventional cardiologists from the United States and India who had two years of experience working together, had previously conducted a comparative study of balloon valvuloplasty and surgery (closed commissurotomy),7 and had performed several hundred balloon-valvuloplasty procedures before this study. Similarly, open commissurotomy was performed by an experienced team of cardiac surgeons from India, the United States, and the United Kingdom, with extensive experience in open mitral commissurotomy. As was the case for the balloon-valvuloplasty procedures, the 30 open commissurotomies were performed during a two-week period; the members of the surgical team who participated in the various operations overlapped, and attempts were made to maintain uniform operative technique.
Limitations of the Study
The patients in this study had characteristics that made them ideal candidates for balloon valvuloplasty and surgical commissurotomy, including an absence of factors known to increase the risk and limit the success of both procedures. However, a substantial number of our patients had characteristics associated with high risk during and after commissurotomy,32 including critical mitral stenosis with mitral-valve areas of ≤ 0.7 cm2 (23 percent) and moderately severe or severe pulmonary hypertension (42 percent had a mean pulmonary-artery pressure >40 mm Hg). Despite our favorable results, caution should be exercised in extrapolating our findings to older patients with high echocardiographic scores, severe subvalvular disease, or thickened, poorly mobile, calcified leaflets or to patients in atrial fibrillation. Studies in less-than-ideal patient groups, especially studies including procedures performed while physicians gained experience,33 have reported higher morbidity and mortality31.
The sex imbalance between the groups does not account for the superior results in the balloon-valvuloplasty group. The mitral-valve areas in the 47 women were identical at base line (0.9 ±0.3 cm2 in both groups), but at the three-year follow-up the valve area was 2.4 ±0.6 cm2 in the women in the balloon-valvuloplasty group and 1.9 ±0.5 cm2 in those who underwent surgery (P = 0.005).
Our study did not compare the double-balloon with the Inoue single-balloon technique, since the latter was not available to the investigators at the beginning of the study. Comparisons of the two techniques have thus far failed to demonstrate a compelling difference in hemodynamic results34-37 or left-to-right shunting38,39. The ability of either technique to open valves in these nearly ideal candidates for the procedure makes it unlikely that our overall findings would have been affected by the choice of valvuloplasty technique40.
Our results suggest that balloon valvuloplasty should be considered for patients with uncomplicated mitral-valve stenosis. Open surgical commissurotomy will continue to be useful for patients with severe subvalvular disease, calcification, or thrombus who are judged to be candidates for plastic procedures rather than mitral-valve replacement. Because mitral commissurotomy is a palliative procedure, the likelihood that thoracotomy will be needed at some point later in the course of the disease is substantial. By avoiding a heart operation early, these patients will avoid the higher rate of complications associated with a second thoracotomy.
The prevalence of rheumatic mitral stenosis in developing countries, where health care funds are limited, will dictate the routine use of balloon valvuloplasty, as long as disposable equipment can be reused safely. In industrialized nations, cost factors also favor balloon valvuloplasty, even without such reuse. The improvement in mitral-valve area after balloon valvuloplasty needs to be considered in the light of the one late death from cardiovascular causes in our study, the four patients with persistent atrial septal defects, and the one additional case of severe mitral regurgitation. A longer follow-up period will be important (follow-up of seven years is planned). Nevertheless, the shorter hospital stays, avoidance of the discomfort and other problems associated with thoracotomy, and superior hemodynamic results of balloon valvuloplasty dictate that this procedure be considered for all patients with severe mitral stenosis in whom the anatomical features of the valve are favorable.
Presented in part in abstract form at the 63rd and 66th Scientific Sessions of the American Heart Association, Dallas, November 14, 1990, and Atlanta, November 9, 1993.
Supported in part by a grant from the General Electric Company.
We are indebted to the directors of the Nizam's Institute of Medical Sciences for their generosity in making available their facilities and personnel; to Dr. Peter Farkas for analyzing hemodynamic data; to Dr. David Anderson (Guy's Hospital, London) for participating in the open-heart-surgery team; to Drs. D.N. Kumar, N. Krishna Reddy, P. Kishore, Padma Kumar, N.V. Rayadu, Prasad Reddy, M.S. Rao, Sunil Kapoor, B.K.S. Sastry, S. Srinivas, Syamasundera Zampani, Susan Farkas, and Shukri David and Sister Mercy Augustine for assistance in patient care and the collection of clinical data; to Mr. Michael Andersen (deceased), Mr. P. Appaya, Ms. Debbie Boldea, Ms. Priscilla Peters, and the technicians and nurses of the cardiac catheterization laboratory of the Nizam's Institute of Medical Sciences; to the C.R. Bard, Boston Scientific, Namic, Cordis, and Winthrop-Sanofi corporations for generously providing supplies; and to the health ministers of the state of Andhra Pradesh for their continuing support of this work.
Source Information
From the Divisions of Cardiology (V.P.R., J.W., B.S.F., P.M., Z.G.T.) and Cardiothoracic Surgery (L.W.S.), Departments of Internal Medicine and Surgery, Harper Hospital, Wayne State University School of Medicine, Detroit; and the Departments of Cardiology (B.S.R., R.R., S.S.) and Cardiac Surgery (P.R., D.P.R., P.V.S.), the Nizam's Institute of Medical Sciences and MediCiti, Hyderabad, India.
Address reprint requests to Dr. Turi at Wayne State University School of Medicine, Harper Hospital, 3990 John R., Detroit, MI 48201.
- References
References
1
Inoue K ,Owaki T ,Nakamura T ,Kitamura F ,Miyamoto N . Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984;87:394-402
Web of Science | Medline2
Lock JE ,Khalilullah M ,Shrivastava S ,Bahl V ,Keane JF . Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med 1985;313:1515-1518
Full Text | Web of Science | Medline3
Block PC ,Palacios IF ,Block EH ,Tuzcu EM ,Griffin B . Late (two-year) follow-up after percutaneous balloon mitral valvotomy. Am J Cardiol 1992;69:537-541
CrossRef | Web of Science | Medline4
Tuzcu EM ,Block PC ,Griffin BP ,Newell JB ,Palacios IF . Immediate and long-term outcome of percutaneous mitral valvotomy in patients 65 years and older. Circulation 1992;85:963-971
Web of Science | Medline5
Vahanian A ,Michel PL ,Cormier B , et al. Immediate and mid-term results of percutaneous mitral commissurotomy. Eur Heart J 1991;12:Suppl B:84-89
Web of Science | Medline6
The National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants
Web of Science | Medline7
Turi ZG ,Reyes VP ,Raju BS , et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis: a prospective, randomized trial. Circulation 1991;83:1179-1185
Web of Science | Medline8
Hickey MS ,Blackstone EH ,Kirklin JW ,Dean LS . Outcome probabilities and life history after surgical mitral commissurotomy: implications for balloon commissurotomy. J Am Coll Cardiol 1991;17:29-42
CrossRef | Web of Science | Medline9
Chavez AM ,Cosgrove DM III ,Lytle BW , et al. Applicability of mitral valvuloplasty techniques in a North American population. Am J Cardiol 1988;62:253-256
CrossRef | Web of Science | Medline10
Wilkins GT ,Weyman AE ,Abascal VM ,Block PC ,Palacios IF . Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308
CrossRef | Web of Science | Medline11
Flamm MD ,Cohn KE ,Hancock EW . Measurement of systemic cardiac output at rest and exercise in patients with atrial septal defect. Am J Cardiol 1969;23:258-265
CrossRef | Web of Science | Medline12
Hlatky MA ,Boineau RE ,Higginbotham MB , et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-654
CrossRef | Web of Science | Medline13
Turi ZG . Valvuloplasty. Cardiovasc Clin 1993;23:293-326
Medline14
Al Zaibag M ,Ribeiro PA ,Al Kasab S ,Al Fagih MR . Percutaneous double-balloon mitral valvotomy for rheumatic mitral-valve stenosis. Lancet 1986;1:757-761
CrossRef | Web of Science | Medline15
Spencer FC. Acquired disease of the mitral valve. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. Vol. 2. 5th ed. Philadelphia: W.B. Saunders, 1990:1517-22.
16
Gorlin R ,Gorlin SG . Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 1951;41:1-29
CrossRef | Web of Science | Medline17
Come PC ,Riley MF ,Diver DJ ,Morgan JP ,Safian RD ,McKay RG . Noninvasive assessment of mitral stenosis before and after percutaneous balloon mitral valvuloplasty. Am J Cardiol 1988;61:817-825
CrossRef | Web of Science | Medline18
SAS/STAT user's guide: version 6. 4th ed. Cary, N.C.: SAS Institute, 1990.
19
Desideri A ,Vanderperren O ,Serra A , et al. Long-term (9 to 33 months) echocardiographic follow-up after successful percutaneous mitral commissurotomy. Am J Cardiol 1992;69:1602-1606
CrossRef | Web of Science | Medline20
Palacios IF ,Block PC ,Wilkins GT ,Weyman AE . Follow-up of patients undergoing percutaneous mitral balloon valvotomy: analysis of factors determining restenosis. Circulation 1989;79:573-579
CrossRef | Web of Science | Medline21
Villanova C ,Melacini P ,Scognamiglio R , et al. Long-term echocardiographic evaluation of closed and open mitral valvulotomy. Int J Cardiol 1993;38:315-321
CrossRef | Web of Science | Medline22
Yoshida K ,Yoshikawa J ,Akasaka T , et al. Assessment of left-to-right atrial shunting after percutaneous mitral valvuloplasty by transesophageal color Doppler flow-mapping. Circulation 1989;80:1521-1526
CrossRef | Web of Science | Medline23
Herrmann HC ,Lima JA ,Feldman T , et al. Mechanisms and outcome of severe mitral regurgitation after Inoue balloon valvuloplasty: North American Inoue Balloon Investigators. J Am Coll Cardiol 1993;22:783-789
CrossRef | Web of Science | Medline24
Essop MR ,Wisenbaugh T ,Skoularigis J ,Middlemost S ,Sareli P . Mitral regurgitation following mitral balloon valvotomy: differing mechanisms for severe versus mild-to-moderate lesions. Circulation 1991;84:1669-1679
Web of Science | Medline25
Abascal VM ,Wilkins GT ,Choong CY ,Block PC ,Palacios IF ,Weyman AE . Mitral regurgitation after percutaneous balloon mitral valvuloplasty in adults: evaluation by pulsed Doppler echocardiography. J Am Coll Cardiol 1988;11:257-263
CrossRef | Web of Science | Medline26
Pan JP ,Lin SL ,Go JU , et al. Frequency and severity of mitral regurgitation one year after balloon mitral valvuloplasty. Am J Cardiol 1991;67:264-268
CrossRef | Web of Science | Medline27
Serra A ,Bonan R ,Lefevre T , et al. Determinants of hemodynamic restenosis 6 months after balloon mitral valvuloplasty. Circulation 1990;82:Suppl III:III-546 abstract.28
Herrmann HC ,Ramaswamy K ,Isner JM , et al. Factors influencing immediate results, complications, and short-term follow-up status after Inoue balloon mitral valvotomy. Am Heart J 1992;124:160-166
CrossRef | Web of Science | Medline29
Thomas MR ,Monaghan MJ ,Michalis LK ,Jewitt DE . Echocardiographic restenosis after successful balloon dilatation of the mitral valve with the Inoue balloon: experience of a United Kingdom centre. Br Heart J 1993;69:418-423
CrossRef | Web of Science | Medline30
John S ,Bashi VV ,Jairaj PS , et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients. Circulation 1983;68:891-896
CrossRef | Web of Science | Medline31
Cohen DJ ,Kuntz RE ,Gordon SPF , et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med 1992;327:1329-1335
Full Text | Web of Science | Medline32
Dean LS ,Davis K ,Feit F ,Mickel M ,Kennedy JW . Complications and mortality of percutaneous balloon mitral commissurotomy. Circulation 1990;82:Suppl III:III-545 abstract.33
Tuzcu EM ,Block PC ,Palacios IF . Comparison of early versus late experience with percutaneous mitral balloon valvuloplasty. J Am Coll Cardiol 1991;17:1121-1124
CrossRef | Web of Science | Medline34
Cheng TO . Single Inoue balloon catheter versus double Mansfield balloon catheter techniques in percutaneous balloon mitral valvuloplasty. Am J Cardiol 1992;69:574-574
CrossRef | Web of Science | Medline35
Ribeiro PA ,Fawzy ME ,Arafat MA , et al. Comparison of mitral valve area results of balloon mitral valvotomy using the Inoue and double balloon techniques. Am J Cardiol 1991;68:687-688
CrossRef | Web of Science | Medline36
Bassand JP ,Schiele F ,Bernard Y , et al. The double-balloon and Inoue techniques in percutaneous mitral valvuloplasty: comparative results in a series of 232 cases. J Am Coll Cardiol 1991;18:982-989
CrossRef | Web of Science | Medline37
Abdullah M ,Halim M ,Rajendran V ,Sawyer W ,al Zaibag M . Comparison between single (Inoue) and double balloon mitral valvuloplasty: immediate and short-term results. Am Heart J 1992;123:1581-1588
CrossRef | Web of Science | Medline38
Park SJ ,Kim JJ ,Park SW ,Song JK ,Doo YC ,Lee SJ . Immediate and one-year results of percutaneous mitral balloon valvuloplasty using Inoue and double-balloon techniques. Am J Cardiol 1993;71:938-943
CrossRef | Web of Science | Medline39
Ishikura F ,Nagata S ,Yasuda S ,Yamashita N ,Miyatake K . Residual atrial septal perforation after percutaneous transvenous mitral commissurotomy with Inoue balloon catheter. Am Heart J 1990;120:873-878
CrossRef | Web of Science | Medline40
Sharma S ,Loya YS ,Desai DM ,Pinto RJ . Percutaneous mitral valvotomy using Inoue and double balloon technique: comparison of clinical and hemodynamic short term results in 350 cases. Cathet Cardiovasc Diagn 1993;29:18-23
CrossRef | Medline
- Citing Articles (97)
Citing Articles
1
Saeed AL Ahmari, Ahmed Amro, Mohammed AL Otabi, Moheeb AL Abdullah, Saad AL Kasab, Husien AL Amri. (2012) Initial experience of using intracardiac echocardiography (ICE) for guiding balloon mitral valvuloplasty (BMV). Journal of the Saudi Heart Association 24:1, 23-27
CrossRef2
Igor F. Palacios, Dabit Arzamendi. (2012) Percutaneous Mitral Balloon Valvuloplasty for Patients with Rheumatic Mitral Stenosis. Interventional Cardiology Clinics 1:1, 45-61
CrossRef3
Blase A Carabello. (2011) Assessment of the patient with valvular heart disease: An integrative approach. Aswan Heart Centre Science & Practice Series 2011:2, 15
CrossRef4
John W. Petersen, Marian C. Limacher. (2011) Valvular Heart Disease in Aging Women. Current Cardiovascular Risk Reports 5:3, 253-260
CrossRef5
S. Gupta, N. Gupta, P. Arand, A. D. Michaels. (2011) Computerized acoustic cardiography correlates with echocardiography and invasive haemodynamics after percutaneous transvenous mitral commissurotomy. Journal of Medical Engineering & Technology 35:1, 59-64
CrossRef6
Mojtaba Salarifar, Mehrnaz Rezvanfard, Hakimeh Sadeghian, Azam Safir-mardanloo, Nahid Shafii. (2011) Mitral annular calcification predicts immediate results of percutaneous transvenous mitral commissurotomy. Cardiovascular Ultrasound 9:1, 29
CrossRef7
Jing Ping Sun, Joel M. Felner. 2010. Mitral Valve Stenosis. , 38-41.
CrossRef8
Krishnakumar Nair, Harikrishnan Sivadasanpillai, P. Sivasubramonium, Padmakumar Ramachandran, Jaganmohan A. Tharakan, Thomas Titus, V.K. Ajit Kumar, Sivasankaran Sivasubramonian, K. Mahadevan Krishnamoorthy, Santosh Dora. (2010) Percutaneous valvuloplasty for mitral valve restenosis: Postballoon valvotomy patients fare better than postsurgical closed valvotomy patients. Catheterization and Cardiovascular Interventions 76:2, 174-180
CrossRef9
Mohamed Eid Fawzy. (2010) Mitral balloon valvuloplasty. Journal of the Saudi Heart Association 22:3, 125-132
CrossRef10
Osama Rifaie, Adel El-Itriby, Tarek Zaki, Tarek AbdelDayem, Wail Nammas. (2010) Immediate and long-term outcome of multiple percutaneous interventions in patients with rheumatic valvular stenosis. EuroIntervention 6:2, 227-232
CrossRef11
Zoltan G. Turi. (2010) The short but not the long of it; How well does the artery heal after vascular closure?. Catheterization and Cardiovascular Interventions 75:3, 349-350
CrossRef12
OSAMA RIFAIE, MOHAMED ISMAIL, WAIL NAMMAS. (2010) Immediate and Long-Term Outcome of Redo Percutaneous Mitral Valvuloplasty: Comparison with Initial Procedure in Patients with Rheumatic Mitral Restenosis. Journal of Interventional Cardiology 23:1, 1-6
CrossRef13
Jae-Kwan Song, Mi-Jeong Kim, Sung-Cheol Yun, Suk Jung Choo, Jong-Min Song, Hyun Song, Duk-Hyun Kang, Cheol Hyun Chung, Duk Woo Park, Seung Whan Lee, Young-Hak Kim, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Jae Won Lee, Seong-Wook Park, Seung-Jung Park. (2010) Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery 139:1, 103-110
CrossRef14
Hyungtae Kim, Pyo Won Park, Kiick Sung, Young-Tak Lee, Tae-Gook Jun, Wook Sung Kim, Ji-Hyuk Yang, Joomin Hwang. (2010) Mid-Term Results of the Cox Maze III Procedure Combined With Open Mitral Commissurotomy for the Treatment of Rheumatic Mitral Stenosis. Circulation Journal 74:7, 1332-1338
CrossRef15
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2009) 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 54:22, e13-e118
CrossRef16
Andrew C. Steer, Jonathan R. Carapetis. (2009) Prevention and treatment of rheumatic heart disease in the developing world. Nature Reviews Cardiology 6:11, 689-698
CrossRef17
Osama Rifaie, Iman Esmat, Mohamed Abdel-Rahman, Wail Nammas. (2009) Can a Novel Echocardiographic Score Better Predict Outcome after Percutaneous Balloon Mitral Valvuloplasty?. Echocardiography 26:2, 119-127
CrossRef18
David Messika-Zeitoun, Julie Blanc, Bernard Iung, Eric Brochet, Bertrand Cormier, Dominique Himbert, Alec Vahanian. (2009) Impact of Degree of Commissural Opening After Percutaneous Mitral Commissurotomy on Long-Term Outcome. JACC: Cardiovascular Imaging 2:1, 1-7
CrossRef19
Robert O. Bonow, Blase A. Carabello, Kanu Chatterjee, Antonio C. de Leon, David P. Faxon, Michael D. Freed, William H. Gaasch, Bruce W. Lytle, Rick A. Nishimura, Patrick T. O'Gara, Robert A. O'Rourke, Catherine M. Otto, Pravin M. Shah, Jack S. Shanewise, Rick A. Nishimura, Blase A. Carabello, David P. Faxon, Michael D. Freed, Bruce W. Lytle, Patrick T. O'Gara, Robert A. O'Rourke, Pravin M. Shah. (2008) 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology 52:13, e1-e142
CrossRef20
Warren Walsh, Alex Brown, Jonathan Carapetis. (2008) The Diagnosis and Management of Chronic Rheumatic Heart Disease—An Australian Guideline. Heart, Lung and Circulation 17:4, 271-289
CrossRef21
Andrew B. McCann, Darren L. Walters, Con N. Aroney. (2008) Percutaneous Balloon Mitral Commissurotomy in Indigenous versus Non-Indigenous Australians. Heart, Lung and Circulation 17:3, 200-205
CrossRef22
Kameswari Maganti, Vera H. Rigolin, Robert O. Bonow. (2008) Valvular heart disease in women. Current Cardiovascular Risk Reports 2:3, 217-226
CrossRef23
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. Anesthesia & Analgesia 106:3, 685-712
CrossRef24
Michael Ragosta. 2008. Mitral Valve Disorders. , 50-67.
CrossRef25
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. Journal of the American College of Cardiology 50:17, 1707-1732
CrossRef26
Srihari S. Naidu, S. Chiu Wong, Richard M. Steingart. (2007) Interventional Therapies for Heart Failure in the Elderly. Heart Failure Clinics 3:4, 485-500
CrossRef27
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 50:17, e159-e242
CrossRef28
H.-H. Osterhues (federführend), F.M. Baer, M. Kelm, M. Irmer (BNK), K. Ivens, M. Leschke (ALKK), A. Meißner (DGAI), M. Pauschinger, B. Ritter (BNK), J. Röther (DGN). (2007) Kommentar zu den Leitlinien zur perioperativen kardiovaskulären Evaluation bei nichtkardialer Chirurgie der ACC/AHA. Der Kardiologe 1:1, 18-30
CrossRef29
Tsung O. Cheng. (2007) Percutaneous versus surgical treatment of atrial septal defect and of mitral stenosis: Cost-effectiveness in developing versus developed countries. International Journal of Cardiology 116:1, 138
CrossRef30
Srihari S. Naidu, S. Chiu Wong, Richard M. Steingart. (2007) Interventional Therapies for Heart Failure in the Elderly. Clinics in Geriatric Medicine 23:1, 155-178
CrossRef31
MOHAMED E. FAWZY, BAHAA FADEL, HANI AL-SERGANI, MOHAMMED AL AMRI, WALID HASSAN, KHALID ABDULBAKI, MOHAMED SHOUKRI, CHARLES CANVER. (2007) Long-Term Results (Up to 16.5 Years) of Mitral Balloon Valvuloplasty in a Series of 518 Patients and Predictors of Long-Term Outcome. Journal of Interventional Cardiology 20:1, 66-72
CrossRef32
Mohamed Eid Fawzy. (2007) Percutaneous mitral balloon valvotomy. Catheterization and Cardiovascular Interventions 69:2, 313-321
CrossRef33
J.W.H. Blake, G.S. Hanzel, W.W. O'Neill. (2007) Neuro-embolic protection during percutaneous balloon mitral valvuloplasty. Catheterization and Cardiovascular Interventions 69:1, 52-55
CrossRef34
Mehmet Timur Selcuk, Hatice Selcuk, Orhan Maden, Ali Riza Erbay, Ahmet Temizhan, Tolga Aksu, Gul Sevim Saydam, Sule Korkmaz. (2007) The Effect of Percutaneous Balloon Mitral Valvuloplasty on N-Terminal- Pro B- Type Natriuretic Peptide Plasma Levels in Mitral Stenosis. International Heart Journal 48:5, 579-590
CrossRef35
Joanne Ritchie, David Sidebotham. 2007. Valvular Heart Disease. , 158-173.
CrossRef36
Robert O. Bonow, Blase A. Carabello, Kanu Chatterjee, Antonio C. de Leon, David P. Faxon, Michael D. Freed, William H. Gaasch, Bruce Whitney Lytle, Rick A. Nishimura, Patrick T. O’Gara, Robert A. O’Rourke, Catherine M. Otto, Pravin M. Shah, Jack S. Shanewise, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Richard L. Page, Barbara Riegel. (2006) ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary. Journal of the American College of Cardiology 48:3, 598-675
CrossRef37
Robert O. Bonow, Blase A. Carabello, Kanu Chatterjee, Antonio C. de Leon, David P. Faxon, Michael D. Freed, William H. Gaasch, Bruce Whitney Lytle, Rick A. Nishimura, Patrick T. O’Gara, Robert A. O’Rourke, Catherine M. Otto, Pravin M. Shah, Jack S. Shanewise, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Richard L. Page, Barbara Riegel. (2006) ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology 48:3, e1-e148
CrossRef38
Thomas M. Bashore. 2006. Valvuloplastia percutánea con balón. , 310-326.
CrossRef39
Shu Maoqin, He Guoxiang, Song Zhiyuan, Chi Luxiang, Hu Houyuan, Si Liangyi, Zhou Ling, Zhuang Guoqiang. (2005) The clinical and hemodynamic results of mitral balloon valvuloplasty for patients with mitral stenosis complicated by severe pulmonary hypertension. European Journal of Internal Medicine 16:6, 413-418
CrossRef40
PEDRO L. SANCHEZ, MAXIMO RODRIGUEZ-ALEMPARTE, IGNACIO INGLESSIS, IGOR F. PALACIOS. (2005) The Impact of Age in the Immediate and Long-Term Outcomes of Percutaneous Mitral Balloon Valvuloplasty. Journal of Interventional Cardiology 18:4, 217-225
CrossRef41
D. Mergner, P. Rosenberger, K. Unertl, H. K. Eltzschig. (2005) Präoperative Evaluation und perioperatives Vorgehen bei kardialen Risikopatienten. Der Anaesthesist 54:5, 427-441
CrossRef42
Steven R. Bailey. (2005) Open no tine before its time. Catheterization and Cardiovascular Interventions 64:3, 312-313
CrossRef43
Nathan E. Green, Adam R. Hansgen, John D. Carroll. (2004) Initial clinical experience with intracardiac echocardiography in guiding balloon mitral valvuloplasty: Technique, safety, utility, and limitations. Catheterization and Cardiovascular Interventions 63:3, 385-394
CrossRef44
Hiroyuki Nakajima, Junjiro Kobayashi, Ko Bando, Yoshio Yasumura, Satoshi Nakatani, Kohji Kimura, Kazuo Niwaya, Osamu Tagusari, Soichiro Kitamura. (2004) Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: The necessity of the maze procedure. The Annals of Thoracic Surgery 78:3, 800-805
CrossRef45
Ralf Holzer, Qi-Ling Cao, Ziyad M Hijazi. (2004) State of the art catheter interventions in adults with congenital heart disease. Expert Review of Cardiovascular Therapy 2:5, 699-711
CrossRef46
Dheeraj Arora, Pragati Ganjoo, Monica S. Tandon, Mary Abraham. (2004) Anesthetic Considerations in a Patient With Mitral Valve Disease for Posterior Fossa Surgery. Journal of Neurosurgical Anesthesiology 16:3, 244-247
CrossRef47
Heinz M. Loick, Thomas Wichter, Christoph Schmidt. 2004. Mitral Valve Disease. , 103-120.
CrossRef48
Harisios Boudoulas. (2003) Etiology of valvular heart disease. Expert Review of Cardiovascular Therapy 1:4, 523-532
CrossRef49
Paul Das, Bernard Prendergast. (2003) Imaging in mitral stenosis: assessment before, during and after percutaneous balloon mitral valvuloplasty. Expert Review of Cardiovascular Therapy 1:4, 549-557
CrossRef50
Ted Feldman. (2003) Core curriculum for interventional cardiology: Percutaneous valvuloplasty. Catheterization and Cardiovascular Interventions 60:1, 48-56
CrossRef51
J. Thompson Sullebarger, Humberto Coto, Enrique Lopez, Dany Sayad, Hector L. Fontanet. (2003) Transjugular percutaneous Inoue balloon mitral commissurotomy in a patient with inferior vena cava obstruction after liver transplantation. Catheterization and Cardiovascular Interventions 59:2, 261-265
CrossRef52
B Iung, A Vahanian. (2003) Le rétrécissement mitral. Annales de Cardiologie et d'Angéiologie 52:2, 117-124
CrossRef53
Shiv Kumar Choudhary, Jayesh Dhareshwar, Akhil Govil, Balram Airan, Arkalgud Sampath Kumar. (2003) Open mitral commissurotomy in the current era: indications, technique, and results. The Annals of Thoracic Surgery 75:1, 41-46
CrossRef54
Adel M. Zaki, Hussien H. Kasem, Sameh Bakhoum, Magdy Mokhtar, Wael El Nagar, Christopher J. White, Mohamed El Guindy. (2002) Comparison of early results of percutaneous metallic mitral commissurotome with Inoue balloon technique in patients with high mitral echocardiographic scores. Catheterization and Cardiovascular Interventions 57:3, 312-317
CrossRef55
Larry W. Stephenson, Agustin Arbulu, Joseph S. Bassett, Allen Silbergleit, Calvin H. Hughes. (2002) The Michigan Heart: The World's First Successful Open Heart Operation? Part I. Journal of Cardiac Surgery 17:3, 238-246
CrossRef56
Kim A. Eagle, Peter B. Berger, Hugh Calkins, Bernard R. Chaitman, Gordon A. Ewy, Kirsten E. Fleischmann, Lee A. Fleisher, James B. Froehlich, Richard J. Gusberg, Jeffrey A. Leppo, Thomas Ryan, Robert C. Schlant, William L. Winters, Raymond J. Gibbons, Elliott M. Antman, Joseph S. Alpert, David P. Faxon, Valentin Fuster, Gabriel Gregoratos, Alice K. Jacobs, Loren F. Hiratzka, Richard O. Russell, Sidney C. Smith. (2002) ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery???Executive Summary. Anesthesia & Analgesia 94:5, 1052-1064
CrossRef57
Ramesh Arora, Gurcharan Singh Kalra, Sandeep Singh, Saibal Mukhopadhyay, Ashish Kumar, Jagdish Chander Mohan, Madhuri Nigam. (2002) Percutaneous transvenous mitral commissurotomy: Immediate and long-term follow-up results. Catheterization and Cardiovascular Interventions 55:4, 450-456
CrossRef58
Bernard Iung, Alec Vahanian. (2002) The long-term outcome of balloon valvuloplasty for mitral stenosis. Current Cardiology Reports 4:2, 118-124
CrossRef59
Kim A Eagle, Peter B Berger, Hugh Calkins, Bernard R Chaitman, Gordon A Ewy, Kirsten E Fleischmann, Lee A Fleisher, James B Froehlich, Richard J Gusberg, Jeffrey A Leppo, Thomas Ryan, Robert C Schlant, William L Winters, Raymond J Gibbons, Elliott M Antman, Joseph S Alpert, David P Faxon, Valentin Fuster, Gabriel Gregoratos, Alice K Jacobs, Loren F Hiratzka, Richard O Russell, Sidney C Smith. (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary. Journal of the American College of Cardiology 39:3, 542-553
CrossRef60
R Krasuski. (2001) Comparison of results of percutaneous balloon mitral commissurotomy in patients aged ≥65 years with those in patients aged <65 years. The American Journal of Cardiology 88:9, 994-1000
CrossRef61
JK Sharma. (2001) Mitral stenosis: Has balloon dilatation replaced surgery?. Medical Journal Armed Forces India 57:3, 269
CrossRef62
B D Powell, D R Holmes, R A Nishimura, C S Rihal. (2001) Calcium embolism of the coronary arteries after percutaneous mitral balloon valvuloplasty.. Mayo Clinic Proceedings 76:7, 753-757
CrossRef63
José A.M de Souza, Eulogio E Martinez, John A Ambrose, Claudia M.R Alves, Daniel Born, Enio Buffolo, Antonio C.C Carvalho. (2001) Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. Journal of the American College of Cardiology 37:3, 900-903
CrossRef64
L YATES, R HARPER, R PEVERILL, J SMOLICH. (2001) Balloon mitral valvuloplasty at Monash Medical Centre: Follow up of 201 procedures over an 11-year period. Heart, Lung and Circulation 10:2, 83-85
CrossRef65
ZOLTAN G. TURI. (2000) Percutaneous Balloon Valvuloplasty Versus Surgery: Randomized Comparisons. Journal of Interventional Cardiology 13:5, 395-401
CrossRef66
IGOR F. PALACIOS. (2000) Percutaneous Mitral Balloon Valvotomy for Patients with Rheumatic Mitral Stenosis. Journal of Interventional Cardiology 13:5, 343-356
CrossRef67
ALAIN CRIBIER, HÉLÈNE ELTCHANINOFF, RAPHAËLLE CARLOT, CATHERINE BIZET, CARLOS GIRON, STEPHAN CHASSAING, GENEVIEVE DERUMEAUX. (2000) Percutaneous Mechanical Mitral Commissurotomy with the Metallic Valvulotome: Detailed Technical Aspects and Overview of the Results of the Multicenter Registry on 882 Patients. Journal of Interventional Cardiology 13:4, 255-262
CrossRef68
Ted Feldman. (2000) Rheumatic mitral stenosis. Current Treatment Options in Cardiovascular Medicine 2:2, 93-103
CrossRef69
Naoya Hamasaki, Hideyuki Nosaka, Takeshi Kimura, Yoshihisa Nakagawa, Hiroyoshi Yokoi, Masashi Iwabuchi, Takashi Tamura, Masakiyo Nobuyoshi. (2000) Ten-years clinical follow-up following successful percutaneous transvenous mitral commissurotomy: Single-center experience. Catheterization and Cardiovascular Interventions 49:3, 284-288
CrossRef70
Terrence M. Yau, Yasser A.Farag El-Ghoneimi, Susan Armstrong, Joan Ivanov, Tirone E. David. (2000) Mitral valve repair and replacement for rheumatic disease. The Journal of Thoracic and Cardiovascular Surgery 119:1, 53-61
CrossRef71
Asad Z Pathan, Nasser A Mahdi, Miltiadis N Leon, Julio Lopez-Cuellar, Hector Simosa, Peter C Block, Lari Harrell, Igor F Palacios. (1999) Is redo percutaneous mitral balloon valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis?. Journal of the American College of Cardiology 34:1, 49-54
CrossRef72
R. M. McCredie, A. T. Hill, R. M. Allan, I. W. Black. (1998) Percutaneous transseptal mitral valvotomy-progress report. Australian and New Zealand Journal of Medicine 28:6, 805-810
CrossRef73
Robert M Applebaum, Ravi R Kasliwal, Ajay Kanojia, Ashok Seth, Suman Bhandari, Naresh Trehan, Howard E Winer, Paul A Tunick, Itzhak Kronzon. (1998) Utility of three-dimensional echocardiography during balloon mitral valvuloplasty. Journal of the American College of Cardiology 32:5, 1405-1409
CrossRef74
Dieter Faßbender, Henning K. Schmidt, Hubert Seggewiß, Hermann Mannebach, Nicola Bogunovic. (1998) Diagnose und Differentialtherapie der Mitralstenose. Herz 23:7, 420-428
CrossRef75
RobertO. Bonow, Blase Carabello, AntonioC. de Leon, L.Henry Edmunds, BradleyJ. Fedderly, MichaelD. Freed, WilliamH. Gaasch, CharlesR. McKay, RickA. Nishimura, PatrickT. O’Gara, RobertA. O’Rourke, ShahbudinH. Rahimtoola, JamesL. Ritchie, MelvinD. Cheitlin, KimA. Eagle, TimothyJ. Gardner, Arthur Garson, RaymondJ. Gibbons, RobertA. O’Rourke, RichardO. Russell, ThomasJ. Ryan, SidneyC. Smith. (1998) ACC/AHA guidelines for the management of patients with valvular heart disease. Journal of the American College of Cardiology 32:5, 1486-1582
CrossRef76
ALAIN CRIBIER, HÉLÈNE ELTCHANINOFF, RENÉ KONING, PRATAP C. RATH, RAMESH ARORA, ADEL IMAN, MUSTAPHA EL-SAYED, SAMEER DANI, GENEVIÈVE DERUMEAUX, SATEJ JANORKAR, BRICE LETAC. (1998) Update on Percutaneous Mechanical Mitral Commissurotomy. Journal of Interventional Cardiology 11:s5, S73-S76
CrossRef77
S Deshpande. (1998) Epidural analgesia for term vaginal delivery after balloon valvotomy for mitral stenosis at 24 weeks gestation. International Journal of Obstetric Anesthesia 7:3, 177-180
CrossRef78
Jonathan H. Goldman, Alistair Slade, Jonathan Clague. (1998) Cardiogenic shock secondary to mitral stenosis treated by balloon mitral valvuloplasty. Catheterization and Cardiovascular Diagnosis 43:2, 195-197
CrossRef79
Chuan-Rong Chen, Tsung O. Cheng, Ji-Yan Chen, Yi-Guao Huang, Tao Huang, Bin Zhang. (1998) Long-term results of percutaneous balloon mitral valvuloplasty for mitral stenosis: A follow-up study to 11 years in 202 patients. Catheterization and Cardiovascular Diagnosis 43:2, 132-139
CrossRef80
Kean-Wah Lau, Zee-Pin Ding, Susan Quek, Veronica Kwok, Jui-Sung Hung. (1998) Long-term (36–63 month) clinical and echocardiographic follow-up after Inoue balloon mitral commissurotomy. Catheterization and Cardiovascular Diagnosis 43:1, 33-38
CrossRef81
Jui-Sung Hung, Kean-Wah Lau. (1997) Editorial comment: A new view of an old picture. Catheterization and Cardiovascular Diagnosis 42:2, 227-228
CrossRef82
Carabello, Blase A., Crawford, Fred A. Jr., . (1997) Valvular Heart Disease. New England Journal of Medicine 337:1, 32-41
Full Text83
Raúl Moreno, Juan-Luis Delcán, Eulogio García, Julián Villacastín, Ana Ortega, Esther Pérez. (1997) Emergent mitral percutaneous valvuloplasty before emergent liver transplantation. Catheterization and Cardiovascular Diagnosis 41:2, 229-230
CrossRef84
Kean-Wah Lau, Zee-Pin Ding, Jui-Sung Hung. (1997) Percutaneous transvenous mitral commissurotomy versus surgical commissurotomy in the treatment of mitral stenosis. Clinical Cardiology 20:2, 99-106
CrossRef85
Charles R Cannan, Rick A Nishimura, Guy S Reeder, Duane R Ilstrup, Dirk R Larson, David R Holmes, A.Jamil Tajik. (1997) Echocardiographic Assessment of Commissural Calcium: A Simple Predictor of Outcome After Percutaneous Mitral Balloon Valvotomy. Journal of the American College of Cardiology 29:1, 175-180
CrossRef86
Mario F. Pompili, John H. Stevens, Thoms A. Burdon, Lawrence C. Siegel, William S. Peters, Greg H. Ribakove, Bruce A. Reitz. (1996) Port-access mitral valve replacement in dogs. The Journal of Thoracic and Cardiovascular Surgery 112:5, 1268-1274
CrossRef87
Larry S. Dean, Mary Mickel, Raoul Bonan, David R. Holmes, William W. O'Neill, Igor F. Palacios, Shahbudin Rahimtoola, James N. Slater, Kathryn Davis, J.Ward Kennedy. (1996) Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy A report from then national heart, lung, and blood institute balloon valvuloplasty registry. Journal of the American College of Cardiology 28:6, 1452-1457
CrossRef88
Kean-Wah Lau, Zee-Pin Ding, Jui-Sung Hung. (1996) Percutaneous Inoue-balloon valvuloplasty in patients with mitral stenosis and associated moderate mitral regurgitation. Catheterization and Cardiovascular Diagnosis 38:1, 1-7
CrossRef89
Tsung O. Cheng. (1996) Editorial comment: Percutaneous balloon mitral valvuloplasty: The why, the when, the what, and the which. Catheterization and Cardiovascular Diagnosis 37:3, 353-354
CrossRef90
(1996) Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Journal of the American College of Cardiology 27:4, 910-948
CrossRef91
Bernard Iung, Bertrand Cormier, Pierre Ducimetiere, Jean-Marc Porte, Olivier Nallet, Pierre-Louis Michel, Jean Acar, Alec Vahanian. (1996) Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. Journal of the American College of Cardiology 27:2, 407-414
CrossRef92
M Farhat. (1995) Results of percutaneous double-balloon mitral commissurotomy in one medical center in Tunisia. The American Journal of Cardiology 76:17, 1266-1270
CrossRef93
Thibault, George E., . (1995) Studying the Classics. New England Journal of Medicine 333:10, 648-652
Full Text94
Tsung O. Cheng. (1995) Percutaneous balloon mitral valvuloplasty: The why, the when, the what, and the which. Catheterization and Cardiovascular Diagnosis 35:2, 101-102
CrossRef95
(1995) Treatment of Mitral Stenosis. New England Journal of Medicine 332:11, 748-750
Full Text96
Paul A. Robiolio, Thomas M. Bashore. (1995) Spontaneous resolution of percutaneous balloon mitral commissurotomy-related mitral regurgitation. Catheterization and Cardiovascular Diagnosis 34:3, 222-223
CrossRef97
Carabello, Blase A., Crawford, Fred A., . (1994) Therapy for Mitral Stenosis Comes Full Circle. New England Journal of Medicine 331:15, 1014-1015
Full Text
